Scientific Community Mourns The Loss Of Nobel Laureates Bardeen And Luria

Scientific Community Mourns The Loss Of Nobel Laureates Bardeen And Luria John Bardeen & Salvador E. Luria John Bardeen, emeritus professor of electrical engineering and physics at the University of Illinois, and the first person to win two Nobel Prizes in the same field, died January 30, at the age of 82, of a heart attack at Brigham and Women's Hospital in Boston. He had been visiting Boston to consult with specialists about his health problems. In 1947, Bardeen, along with Wa

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In 1947, Bardeen, along with Walter Brattain and William P. Schockley, developed the first semiconductor transistor at AT&T Bell Laboratories in Murray Hill, N.J. The invention was first used commercially in telephone switching equipment in 1952. The three scientists won the Nobel Prize in physics in 1956 for their invention, which heralded the dawn of modern electronics by replacing the vacuum tube.

In 1951, Bardeen joined the University of Illinois faculty, where he would develop a theory of low-temperature superconductivity, which he considered his greatest professional accomplishment. In 1972, he won his second Nobel Prize for this research, along with two scientists who worked with him as graduate students, Leon Cooper and J. Robert Schreiffer. He retired in 1975.

Bardeen received his B.S. in 1928 and his M.S. in 1929, both in electrical engineering from the University of Wisconsin, Madison. After working as a geophysicist at Gulf Research Laboratories in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies